FdaApplication

BLA 125151

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTakeda Pharmaceuticals U.S.A., Inc.
application_typeBLA
approval_date2006-07-24

Products (1)

ProductActive ingredientStrengthDosage form
ELAPRASEIDURSULFASE6MG/3ML (2MG/ML)INJECTABLE;IV (INFUSION)

1 product